icon_arrow_bulkyicon_arrow_thinicon_blogicon_bookmarkicon_calendaricon_chevron_closedicon_chevron_openicon_closeicon_commenticon_documenticon_downloadicon_eguideicon_globeicon_lawnowicon_linkedinicon_listicon_locationicon_mailicon_menuicon_newsicon_newslettericon_phoneicon_pinicon_printicon_replyicon_retweeticon_searchicon_shareicon_share_alticon_staricon_targeticon_thumbs_upicon_twittericon_uploadicon_user_cardicon_usersicon_xing

Recently published

Jurisdiction / Region

  • Loading...

More information

Expertise

CMS Worldwide

Selected jurisdiction

Types

Latest news

Press contact

Types

Recommended

Latest

Jurisdiction

404 - Page not found

404 - Page not found




Unfortunately, we can’t seem to find the page you’re looking for.

Error code: 404

Topics

Types

Next Events

Calendar

CMS on LinkedIn

Follow us

side view of scientist looking into microscope in bright research lab

Lifesciences

China

As a participant in the lifesciences industry, you know that discovery and innovation are key to finding lasting health solutions. Yet due to the highly regulated nature of the industry, you - a corporate, investor or start-up - must overcome complex administrative, compliance and liability hurdles before your products and services can come to market. With over 150 international specialists across CMS and the support of the Lifesciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your business.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in the major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day to day operational needs such as support with public sector procurement, patent prosecution and enforcement, commercial agreements, tax and transfer pricing, and regulatory advice. Equally, when you need lifesciences specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Read more Read less
11/07/2016
Ex­pect­a­tion of a Faster Growth of Health Food in Near...
China In­sight - Lifes­ci­ences
05/04/2016
New GCP of Med­ic­al Devices
China In­sight - Lifes­ci­ences
05/04/2016
China En­cour­ages In­nov­at­ive Drug by Modi­fy­ing Its Drug...
China In­sight - Lifes­ci­ences

Feed

Show only
30/08/2017
The leg­al and reg­u­lat­ory chal­lenges of get­ting a bi­osim­il­ar product...
After a pharma view on bi­osim­il­ars was provided in the pre­vi­ous Ex­pert View column, a leg­al per­spect­ive is provided by Nick Beck­ett, man­aging part­ner at CMS Beijing and glob­al co-head of the firm­'s lifes­ci­ences sec­tor group.
21/06/2017
The Ver­dict - Round-up of cor­por­ate crime de­vel­op­ments across CMS
We are pleased to send our new is­sue of The Ver­dict, an at-a-glance round-up of re­cent leg­al de­vel­op­ments in re­la­tion to cor­por­ate crime. In this is­sue, the spot­light is on some sig­ni­fic­ant changes to anti-cor­rup­tion laws in the Czech Re­pub­lic, in­clud­ing.
10/02/2017
In­dia Budget 2017 - 2018
On 1 Feb­ru­ary, Fin­ance Min­is­ter Ar­un Jait­ley presen­ted In­dia’s an­nu­al Uni­on Budget for 2017-2018 (the “Budget”) for the fisc­al year be­gin­ning 1 April 2017. The cent­ral aim in this year’s Budget ap­pears to fo­cus on the most vul­ner­able with in­creased spend­ing.